NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
NOTE 1 — ORGANIZATION AND PLAN
OF BUSINESS OPERATIONS
AIB Acquisition Corporation
(the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on June 18, 2021. The Company was
formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar
business combination with one or more businesses (“Business Combination”).
The Company is not limited
to a particular industry or geographic region for purposes of completing a Business Combination, although the Company intends to focus
on business in the fintech industry. Notwithstanding the foregoing, we will not pursue a target business that is headquartered in, or
conducts a majority of its business in, China or Hong Kong. The Company is an early stage and emerging growth company and, as such, the
Company is subject to all of the risks associated with early stage and emerging growth companies.
As of December 31, 2022,
the Company had not commenced any operations. All activity from June 18, 2021 (inception) through December 31, 2022, relates to the Company’s
formation and Initial Public Offering (“IPO”), which is described below and, since the IPO, the search for a prospective Business
Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the
earliest. The Company will generate non-operating income in the form of interest income earned on investments from the proceeds derived
from the IPO. The registration statement for the Company’s IPO was declared effective on January 18, 2022. On January 21, 2022,
the Company consummated the IPO of 7,500,000 units (“Units”) with respect to the Class A ordinary shares (“Class A ordinary
shares”) included in the Units being offered (the “Public Shares”) at $10.00 per Unit generating gross proceeds
of $75,000,000, which is discussed in Note 3. The Company has selected December 31 as its fiscal year end.
Simultaneously with the closing
of the IPO, the Company consummated the sale of 355,000 private placement units (“Private Placement Units”) at a price of
$10.00 per Private Placement Unit in a private placement to the Company’s sponsor, AIB, LLC (the “Sponsor”), and
Maxim Group, LLC (“Maxim”) generating gross proceeds of $3,550,000 which is described in Note 4.
Simultaneously with the closing
of the IPO and the sale of the Private Placement Units, the Company consummated the closing of the sale of 1,125,000 additional Units
upon receiving notice of the underwriter’s election to fully exercise its overallotment option (“Overallotment Units”),
generating additional gross proceeds of $11,250,000. Simultaneously with the exercise of the overallotment, the Company consummated the
private placement of an additional 33,750 Private Placement Units to the Sponsor and Maxim, generating gross proceeds of $337,500.
Offering costs for the IPO
and Overallotment Units amounted to $5,941,695, consisting of $1,725,000 of underwriting fees, $3,018,750 of deferred underwriting fees
payable (which are held in the Trust Account (defined below)), $56,000 for the underwriter’s unit purchase option (see Note 6),
$598,000 for the issuance of representative shares to the underwriters (see Note 7) and $543,945 of other costs. As described in Note
6, the $3,018,750 of deferred underwriting fees payable is contingent upon the consummation of a Business Combination, subject to the
terms of the underwriting agreement.
Following the closing of
the IPO and Overallotment Units, $87,112,500 ($10.10 per Unit) from the net proceeds of the sale of the Units in the IPO, Overallotment
Units, and the Private Placement Units were placed in a trust account (“Trust Account”). The amounts placed in the Trust Account
will be invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act of
1940, as amended (the “Investment Company Act”), with a maturity of 180 days or less or in any open-ended investment company
that holds itself out as a money market fund selected by the Company meeting the conditions of paragraphs (d)(2), (d)(3) and (d)(4) of
Rule 2a-7 of the Investment Company Act, as determined by the Company, until the earlier of: (i) the completion of a Business
Combination and (ii) the distribution of the Trust Account, as described below.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
The Company’s management
has broad discretion with respect to the specific application of the net proceeds of the IPO and the sale of the Private Placement Units,
although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There
is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete one or more initial
Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the amounts
due under the business combination marketing agreement and taxes payable on income earned on the Trust Account) at the time of the agreement
to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction
company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in
the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance
the Company will be able to successfully effect a Business Combination.
The Company will provide
the holders of the outstanding Public Shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of
their Public Shares upon the completion of a Business Combination either (i) in connection with a shareholder meeting called to approve
the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval
of a Business Combination or conduct a tender offer will be made by the Company. The Public Shareholders will be entitled to redeem their
Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.10 per Public Share, plus
any pro rata interest then in the Trust Account, net of taxes payable).
All of the Public Shares
contain a redemption feature which allows for the redemption of such Public Shares in connection with the Company’s liquidation,
if there is a shareholder vote or tender offer in connection with the Company’s Business Combination and in connection with certain
amendments to the Company’s amended and restated certificate of incorporation. In accordance with Financial Accounting Standards
Board (“FASB”) Accounting Standards Codification (“ASC”) Topis 480 “Distinguishing Liabilities from Equity”
(“ASC 480”) Subtopic 10-S99, redemption provisions not solely within the control of a company require Class A ordinary shares
subject to redemption to be classified outside of permanent equity. Given that the Public Shares will be issued with other freestanding
instruments (i.e., Public Rights as defined in Note 7), the initial carrying value of the Public Shares classified as temporary equity
will be the allocated proceeds determined in accordance with ASC 470-20 “Debt with Conversion and other Options”. The Public
Shares are subject to ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option
to either (i) accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable
that the instrument will become redeemable, if later) to the earliest redemption date of the instrument or (ii) recognize changes in the
redemption value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of
each reporting period. The Company has elected to recognize the changes immediately. While redemptions cannot cause the Company’s
net tangible assets to fall below $5,000,001, the Public Shares are redeemable and are classified as such on the balance sheet until such
date that a redemption event takes place.
Redemptions of the Company’s
Public Shares may be subject to the satisfaction of conditions, including minimum cash conditions, pursuant to an agreement relating to
the Company’s Business Combination. If the Company seeks shareholder approval of the Business Combination, the Company will proceed
with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination, or such other vote as required
by law or stock exchange rule. If a shareholder vote is not required by applicable law or stock exchange listing requirements and the
Company does not decide to hold a shareholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated
Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange
Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder
approval of the transaction is required by applicable law or stock exchange listing requirements, or the Company decides to obtain shareholder
approval for business or other reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the
proxy rules and not pursuant to the tender offer rules. If the Company seeks shareholder approval in connection with a Business Combination,
the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the IPO in favor
of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares without voting, and
if they do vote, irrespective of whether they vote for or against the proposed transaction.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
Notwithstanding the foregoing,
the Amended and Restated Memorandum and Articles of Association provides that a Public Shareholder, together with any affiliate of such
shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13
of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with
respect to more than an aggregate of 15% or more of the Public Shares sold in the IPO, without the prior consent of the Company.
The Company’s Sponsor,
officers and directors (the “Initial Shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum
and Articles of Association that would affect the substance or timing of the Company’s obligation to redeem 100% of its Public Shares
if the Company does not complete a Business Combination, unless the Company provides the Public Shareholders with the opportunity to redeem
their shares of Class A ordinary shares in conjunction with any such amendment.
If the Company is unable
to complete a Business Combination by January 21, 2023, 12 months from the closing of the IPO, or up to 21 months if extended (see Note
5), (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as
promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares, at a per-share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account including interest earned on the funds held in the Trust Account
and not previously released to the Company to pay (i) its income and franchise taxes and (ii) up to $100,000 of dissolution expenses,
if any, divided by the number of then outstanding Public Shares, which redemption will completely extinguish Public Shareholders’
rights as shareholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as
promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and the
Company’s board of directors, dissolve and liquidate, subject in each case to the Company’s obligations under Cayman Islands
law to provide for claims of creditors and the requirements of other applicable law. On January 19, 2023, upon the shareholders’
approval of the Trust Amendment Proposal, the Company entered into an amendment (the “Trust Amendment”) to the Investment
Management Trust Agreement, dated January 18, 2022 (the “Trust Agreement”), by and between the Company and Continental Stock
Transfer & Trust Company, as trustee (“Continental”), to extend the date by which the Company would be required to consummate
a business combination from January 21, 2023 to October 21, 2023, or such earlier date as determined by the board of directors of the
Company (the “Board”), in its sole discretion (see Note 9).
On January 20, 2023, the
Company issued a promissory note (the “Extension Note”) in the aggregate principal amount of up to $450,000 to AIB LLC, a
Delaware limited liability company, the Company’s sponsor (the “Extension Funds”), pursuant to which the Extension Funds
will be deposited into the Trust Account in monthly installments for the benefit of each outstanding Class A ordinary share of the Company
(“Public Share”) that was not redeemed in connection with the extension of the Company’s termination date from January
21, 2023 to October 21, 2023. The sponsor has agreed to pay $50,000 per month (or $0.05 per public share not redeemed) that the Company
decides to take to complete an initial business combination, commencing on January 21, 2023 and continuing through October 21, 2023, or
portion thereof, that is needed to complete an initial business combination, for up to an aggregate of $450,000. On January 20, 2023,
the first installment of the Extension Funds was deposited into the Trust Account (see Note 9). The Extension Note bears no interest and
is repayable in full upon the earlier of (a) the date of the consummation of the initial business combination, and (b) the date of the
liquidation of the Company.
In connection with the shareholders’
vote at the extraordinary general meeting of shareholders. Shareholders holding 7,623,698 shares of the Company’s ordinary shares
exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account. As a result, $78,324,476
(approximately $10.27 per share) was removed from the Trust Account to pay such holders (Note 9).
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
The Initial Shareholders
have agreed to waive their liquidation rights with respect to the Founder Shares (as defined in Note 5) if the Company fails to complete
a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the
IPO, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails
to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to its deferred underwriting
commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination
Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund
the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets
remaining available for distribution (including Trust Account assets) will be only $10.10 per share initially held in the Trust Account.
In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any
claims by a vendor for services rendered or products sold to the Company, or a prospective target business with which the Company has
discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply with respect
to any claims by a third party who executed a waiver of any right, title, interest or claim of any kind in or to any monies held in the
Trust Account or to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including
liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed
waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such
third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims
of creditors by endeavoring to have all vendors, service providers, prospective target businesses or other entities with which the Company
does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the
Trust Account.
Risks and Uncertainties
Management is currently evaluating
the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect
on the Company’s financial position, results of its operations, and/or search for a target company, the specific impact is not readily
determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from
the outcome of this uncertainty.
In February 2022, the Russian
Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including
the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and
related sanctions on the world economy is not determinable as of the date of these financial statements. The specific impact on the Company’s
financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.
On August 16, 2022, the Inflation
Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S.
federal 1% excise tax on certain repurchases (including redemptions) of stock by publicly traded domestic (i.e., U.S.) corporations and
certain domestic subsidiaries of publicly traded foreign corporations. The excise tax is imposed on the repurchasing corporation itself,
not its shareholders from which shares are repurchased. The amount of the excise tax is generally 1% of the fair market value of the shares
repurchased at the time of the repurchase. However, for purposes of calculating the excise tax, repurchasing corporations are permitted
to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same taxable
year. In addition, certain exceptions apply to the excise tax. The U.S. Department of the Treasury (the “Treasury”) has been
given authority to provide regulations and other guidance to carry out and prevent the abuse or avoidance of the excise tax. The IR Act
applies only to repurchases that occur after December 31, 2022.
Any redemption or other repurchase
that occurs after December 31, 2022, in connection with a Business Combination, extension vote or otherwise, may be subject to the excise
tax. Whether and to what extent the Company would be subject to the excise tax in connection with a Business Combination, extension vote
or otherwise would depend on a number of factors, including (i) the fair market value of the redemptions and repurchases in connection
with the Business Combination, extension or otherwise, (ii) the structure of a Business Combination, (iii) the nature and amount of any
“PIPE” or other equity issuances in connection with a Business Combination (or otherwise issued not in connection with a Business
Combination but issued within the same taxable year of a Business Combination) and (iv) the content of regulations and other guidance
from the Treasury. In addition, because the excise tax would be payable by the Company and not by the redeeming holder, the mechanics
of any required payment of the excise tax have not been determined. The foregoing could cause a reduction in the cash available on hand
to complete a Business Combination and in the Company’s ability to complete a Business Combination. Because there is a possibility
that the Company may acquire a U.S. domestic corporation or engage in a transaction in which a domestic corporation becomes our parent
or our affiliate and our securities will trade on Nasdaq following the date of this prospectus, we may become a “covered corporation”.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
Liquidity and Going Concern
As of December 31, 2022,
the Company had $44,217 in its operating bank account, and working capital deficit of $59,776.
The Company’s liquidity
needs up to the closing of the IPO on January 21, 2022 had been satisfied through proceeds from notes payable and advances from related
party and from the issuance of ordinary shares.
In order to finance transaction
costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s
officers and directors may, but are not obligated to, provide the Company with working capital. The Company’s management plans to
continue its efforts to complete a Business Combination within the Combination Period after the closing of the Initial Public Offering.
On January 20, 2023, the
Company issued the Extension Note in the aggregate principal amount of up to $450,000 to its sponsor, pursuant to which the Extension
Funds will be deposited into the Trust Account in monthly installments for the benefit of each outstanding Public Share that was not redeemed
in connection with the extension of the Company’s termination date from January 21, 2023 to October 21, 2023. The sponsor has agreed
to pay $50,000 per month (or $0.05 per public share not redeemed) that the Company decides to take to complete an initial business combination,
commencing on January 21, 2023 and continuing through October 21, 2023, or portion thereof, that is needed to complete an initial business
combination, for up to an aggregate of $450,000. On January 20, 2023, the first installment of the Extension Funds was deposited into
the Trust Account (see Note 9). The Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the
consummation of the initial business combination, and (b) the date of the liquidation of the Company.
On January 23, 2023, the
Company, issued a promissory note (the “2023 Note”) in the principal amount of up to $500,000 to the Sponsor. The 2023 Note
was issued in connection with advances the Sponsor has made, and may make in the future, to the Company for working capital expenses.
The 2023 Note bears no interest and is due and payable upon the earlier to occur of (i) the date on which the Company consummates its
initial business combination and (ii) the date that the winding up of the Company is effective. At the election of the Sponsor, up to
$500,000 of the unpaid principal amount of the 2023 Note may be converted into units of the Company, each unit consisting of one Class
A ordinary share of the Maker and one right exchangeable into one-tenth of one Class A ordinary share of the Company (the “Conversion
Units”), equal to: (x) the portion of the principal amount of this 2023 Note being converted, divided by (y) $10.00, rounded up
to the nearest whole number of units. The Conversion Units are identical to the units issued by the Company to the Sponsor in the private
placement upon consummation of the Company’s initial public offering. The Conversion Units and their underlying securities are entitled
to the registration rights set forth in the Note (see Note 9).
If our estimate of the costs
of identifying a target business, undertaking in-depth due diligence and negotiating a business combination are less than the actual amount
necessary to do so, we may have insufficient funds available to operate our business prior to our business combination. Moreover, we may
need to obtain other financing either to complete our business combination or because we become obligated to redeem a significant number
of our public shares upon consummation of our business combination, in which case we may issue additional securities or incur debt in
connection with such business combination. Subject to compliance with applicable securities laws, we would only complete such financing
simultaneously with the completion of our business combination. If we are unable to complete our business combination because we do not
have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our
business combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
On January 19, 2023, upon
the shareholders’ approval of the Trust Amendment Proposal, the Company entered into the Trust Amendment to extend the date by which
the Company would be required to consummate a business combination from January 21, 2023 to October 21, 2023, or such earlier date as
determined by the Board, in its sole discretion (see Note 9). As a result, we have up to 21 months from the closing of the Initial Public
Offering on January 21, 2022 to consummate a Business Combination, unless further extended as permitted by our charter. It is uncertain
that we will be able to consummate a Business Combination by this time. If a Business Combination is not consummated by this date, there
will be a mandatory liquidation and subsequent dissolution.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
In connection with the Company’s
assessment of going concern considerations in accordance with FASB ASC Topic 205-40, “Presentation of Financial Statements —
Going Concern”, management has determined that mandatory liquidation, should a Business Combination not occur, and potential subsequent
dissolution raises substantial doubt about the Company’s ability to continue as a going concern for a reasonable period of time,
which is considered to be one year from the issuance of the financial statements.
NOTE 2 — SUMMARY OF SIGNIFICANT
ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial
statements are presented in U.S. dollars and have been prepared in accordance with accounting principles generally accepted in the United
States of America (“U.S. GAAP”) and pursuant to the accounting and disclosure rules and regulations of the SEC.
Emerging Growth Company
The Company is an “emerging
growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups
Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are
applicable to other public companies that are not emerging growth companies, including, but not limited to, not being required to comply
with the independent registered public accounting firm attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002,
reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the
requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments
not previously approved.
Further, Section 102(b)(1) of
the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until
private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class
of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS
Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period
which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company,
as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.
This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company
nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential
differences in accounting standards used.
Use of Estimates
The preparation of the financial
statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of
revenues and expenses during the reporting periods.
Making estimates requires
management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation
or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly
from those estimates.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
Cash and Cash Equivalents
The Company considers all
short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had $44,217
and $45,370 in cash and did not have any cash equivalents as of December 31, 2022 and 2021, respectively.
Investments Held in Trust Account
At December 31, 2022, substantially
all of the assets held in the Trust Account were held in U.S. Treasury securities. The Company’s investments held in the Trust Account
are classified as trading securities. Trading securities are presented on the balance sheet at fair value at the end of each reporting
period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned
on marketable securities held in Trust Account in the accompanying statement of operations. The estimated fair values of investments held
in Trust Account are determined using available market information.
The securities are presented
on the balance sheets at fair value at the end of each reporting period. Earnings on these securities are included in dividends, interest
earned, and unrealized gain on investments held in Trust Account in the accompanying statements of operations and are automatically reinvested.
The fair value for these securities is determined using quoted market prices in active markets for identical assets.
During the year ended December
31, 2022, interest earned from the Trust account amounted to $1,383,127 (including $624,913 accrued interest on investments purchased
on October 27, 2022 maturing on January 26, 2023) of which $758,165 was reinvested and $49 was held in Cash in the Trust Account. $29,948
was also recognized as unrealized gain on investments held in the Trust account during the year ended December 31, 2022. There were no
withdrawals made during the year ended December 31, 2022.
Class A Ordinary shares subject to Possible Redemption
The Company accounts for
its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Shares of Class A ordinary shares
subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable
Class A ordinary shares (including Class A ordinary shares that features redemption rights that are either within the control of the holder
or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary
equity. At all other times, Class A ordinary shares are classified as shareholders’ equity. The Company’s Public Shares sold
in the IPO feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence
of uncertain future events. Accordingly, on December 31, 2022, 8,625,000 shares of Class A ordinary shares subject to possible redemption
are presented as temporary equity, outside of the shareholders’ deficit section of the Company’s balance sheet. There were
no Class A ordinary shares subject to possible redemption outstanding as of December 31, 2021.
As of December 31, 2022,
the shares of Class A ordinary shares subject to possible redemption reflected on the balance sheet are reconciled on the following table:
Gross proceeds | |
$ | 86,250,000 | |
Less: | |
| | |
Fair value of Public Rights at issuance | |
| (6,272,000 | ) |
Class A shares issuance costs | |
| (5,506,764 | ) |
Plus: | |
| | |
Accretion of carrying value to redemption value | |
| 12,641,264 | |
Class A ordinary shares subject to possible redemption, January 21, 2022 | |
$ | 87,112,500 | |
Plus: Subsequent accretion of carrying value to redemption value | |
| 1,413,075 | |
Class A ordinary shares subject to possible redemption, December 31, 2022 | |
$ | 88,525,575 | |
Offering Costs associated with the Initial Public Offering
Offering costs consist principally
of legal, accounting, underwriting fees and other costs directly related to the IPO. Offering costs amounted to $5,941,695 which were
charged against shareholders’ deficit upon the completion of the IPO.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
Concentration of Credit Risk
Financial instruments that
potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times,
may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. As of December 31, 2022 and 2021 the Company has not
experienced losses on these accounts and management believes the Company is not exposed to significant risks on such account.
Fair Value of Financial Instruments
The fair value of the Company’s
assets and liabilities, which qualify as financial instruments under ASC 820, “Fair Value Measurements and Disclosures,” equals
or approximates the carrying amounts represented in the accompanying balance sheets, primarily due to their short-term nature.
Income Taxes
The Company accounts for
income taxes under ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred
tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities
and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires
a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
ASC 740 also clarifies
the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold
and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities.
The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized
tax benefits and no amounts accrued for interest and penalties as of December 31, 2022 and 2021. The Company is currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is
subject to income tax examinations by major taxing authorities since inception.
The Company is a Cayman Islands
exempted company and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.
As such, the Company’s tax provision was zero for the period presented.
Net Income (Loss) Per Ordinary Share
The Company has two outstanding
classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares (the “Founder Shares”). Class
A shares include redeemable and non-redeemable shares. Earnings and losses are shared pro rata between the two classes of shares which
includes Class A ordinary shares and Class B ordinary shares and between the redeemable and the non-redeemable shares. The 9,095,975
Class A ordinary shares for which the outstanding Public Rights and Private Placement Rights are exercisable were excluded from diluted
earnings per share for the period ended December 31, 2022 because they are contingently exercisable, and the contingencies have not yet
been met. As a result, diluted net income per ordinary share is the same as basic net income per ordinary share for the period. The table
below presents a reconciliation of the numerator and denominator used to compute basic and diluted net loss per share for each class of
shares.
FOR THE YEAR ENDED DECEMBER 31, 2022 |
| |
Redeemable | | |
Non-redeemable | |
NUMERATOR | |
Class A | | |
Class A | | |
Class B | |
Numerator: | |
| | |
| | |
| |
Allocation of net loss | |
$ | (10,202,485 | ) | |
$ | (557,115 | ) | |
$ | (2,706,328 | ) |
Accretion of temporary equity to redemption value | |
| 12,641,264 | | |
| — | | |
| — | |
Net income including accretion of temporary equity to redemption value | |
| 1,413,075 | | |
| — | | |
| — | |
Net income (loss) | |
$ | 3,851,854 | | |
$ | (557,115 | ) | |
$ | (2,706,328 | ) |
Denominator: | |
| | | |
| | | |
| | |
Weighted Average Shares Outstanding including ordinary shares subject to redemption | |
| 8,128,767 | | |
| 443,878 | | |
| 2,156,250 | |
Basic and diluted net income (loss) per share | |
$ | 0.47 | | |
$ | (1.26 | ) | |
$ | (1.26 | ) |
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
FOR THE PERIOD FROM JUNE 18, 2021 (INCEPTION) THROUGH DECEMBER 31, 2021 |
| |
Redeemable | | |
Non-redeemable | |
NUMERATOR | |
Class A | | |
Class A | | |
Class B | |
Numerator: | |
| | |
| | |
| |
Allocation of net loss | |
$ | — | | |
$ | — | | |
$ | (23,277 | ) |
Accretion of temporary equity to redemption value | |
| — | | |
| — | | |
| — | |
Net loss including accretion of temporary equity to redemption value | |
| — | | |
| — | | |
| — | |
Net loss | |
$ | — | | |
$ | — | | |
$ | (23,277 | ) |
Denominator: | |
| | | |
| | | |
| | |
Weighted Average Shares Outstanding including ordinary shares subject to redemption | |
| — | | |
| — | | |
| 1,875,000 | |
Basic and diluted net loss per share | |
$ | — | | |
$ | — | | |
$ | (0.01 | ) |
NOTE 3 — INITIAL PUBLIC OFFERING
Pursuant to the IPO, the
Company sold 8,625,000 Units (including 1,125,000 Overallotment Units) at a price of $10.00 per Unit. Each Unit consists of one share
of Class A ordinary shares and one right (the “Public Rights”). Each Public Right entitles the holder to receive one-tenth
(1/10) of one Class A ordinary share upon the consummation of a Business Combination (see Note 7).
NOTE 4 — PRIVATE PLACEMENT
On January 21, 2022,
simultaneously with the consummation of the IPO and sale of the Overallotment Units, the Company consummated the issuance and sale of
388,750 Private Placement Units (including 33,750 Private Placement Units purchased simultaneously with the Overallotment Units) in a
private placement transaction at a price of $10.00 per Private Placement Unit, generating gross proceeds of $3,887,500 to the Sponsor
(345,625 Private Placement Units) and Maxim (43,125 Private Placement Units). Each Private Placement Unit consists of one share of
Class A ordinary shares and one right (the “Private Placement Rights”). Each Private Placement Right will entitle the holder
thereof to receive one-tenth (1/10) of one Class A ordinary (“Private Placement Share”) share upon the consummation of a Business
Combination.
A portion of the proceeds
from the Private Placement Units were added to the proceeds from the IPO to be held in the Trust Account. If the Company does not complete
a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Units will be used to fund the
redemption of the Public Shares (subject to the requirements of applicable law), and the Private Placement Units and any underlying securities
will be worthless.
NOTE 5 — RELATED PARTY TRANSACTIONS
Founder Shares
On July 30, 2021, the Sponsor
purchased 1,437,500 Founder Shares for an aggregate price of $25,000. (See Note 7). On September 13, 2021, the Company effected a 0.5-for-1
split of the Company’s Class B ordinary shares, such that the Sponsor owned 2,156,250 Founder Shares. The Founder Shares will automatically
convert into shares of Class A ordinary shares at the time of the Company’s initial Business Combination and are subject to certain
transfer restrictions, as described in Note 7. Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares
into an equal number of shares of Class A ordinary shares, subject to adjustment, at any time. The Initial Shareholders agreed to forfeit
up to 281,250 Founder Shares to the extent that the over-allotment option is not exercised in full by the underwriters. Since the overallotment
option was exercised in full, the 281,250 Founder Shares are no longer subject to forfeiture.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
The Sponsor has agreed, subject
to limited exceptions, not to transfer, assign or sell any of its Founder Shares until the earlier to occur of: (A) six months after the
completion of a Business Combination; and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares
equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and
the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after a Business Combination, or (y) the
date on which the Company completes a liquidation, merger, amalgamation, share exchange, reorganization or other similar transaction that
results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or
other property.
Administrative Services Agreement
The Company intends to pay
the Sponsor a fee of up to $10,000 per month for the use of office and administrative support services following the consummation of the
IPO until the earlier of the consummation of the Business combination or liquidation for office space and administrative services. For
the year ended December 31, 2022, the Company incurred and paid $114,000 fees for these services. For the period from June 18, 2021 (Inception)
through December 31, 2021, no amounts have been accrued under this agreement.
Promissory Note – Related Party
On July 30, 2021, the Sponsor
agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the IPO pursuant to the First Note. The First
Note is non-interest bearing. On January 21, 2022, the First Note was repaid in full.
Related Party Loans
In addition, in order to
finance transaction costs in connection with a Business Combination, certain of the Company’s officers and directors may, but are
not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business
Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise,
the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does
not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds
held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital
Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either
be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such
Working Capital Loans may be convertible into units of the post Business Combination entity at a price of $10.00 per unit. These units
would be identical to the Private Placement Units. As of December 31, 2022 and 2021 there were no Working Capital Loans outstanding.
Related Party Extension Loans
As discussed in Note 1, the
Company may extend the period of time to consummate a Business Combination up to three times, each by an additional three months (for
a total of 21 months to complete a Business Combination). In order to extend the time available for the Company to consummate a Business
Combination, the Sponsor or its affiliates or designees must deposit into the Trust Account $862,500 ($0.10 per Public Share or an aggregate
of $2,587,500), on or prior to the date of the applicable deadline, for each three month extension. Any such payments would be made in
the form of a non-interest bearing, unsecured promissory note. Such notes would be paid upon consummation of a Business Combination. The
Sponsor and its affiliates or designees are not obligated to fund the Trust Account to extend the time for the Company to complete a Business
Combination.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
On January 20, 2023, the
Company issued the Extension Note in the aggregate principal amount of up to $450,000 to the Sponsor, the Company’s Sponsor, pursuant
to which the Extension Funds will be deposited into the Trust Account in monthly installments for the benefit of each outstanding Public
Share that was not redeemed in connection with the extension of the Company’s termination date from January 21, 2023 to October
21, 2023 (see Note 9).
On January 23, 2023, the
Company, issued the Third Note in the principal amount of up to $500,000 to the Sponsor. The Third Note was issued in connection with
advances the Sponsor has made, and may make in the future, to the Company for working capital expenses (see Note 9).
Advance from Related Party
As of December 31, 2022 the
Sponsor have paid for expenses totaling $67,910 on behalf of the Company. Amounts due from the Sponsor amounting to $26,445 was offset
against the advance. $41,465 is included in advance from related party on the balance sheet as of December 31, 2022.
NOTE 6 — COMMITMENTS AND CONTINGENCIES
Registration Rights
The holders of the Founder
Shares, Private Placement Units and units that may be issued upon conversion of the Working Capital Loans (and all underlying securities)
will be entitled to registration rights pursuant to a registration rights agreement to be signed prior to or on the effective date of
the IPO. The holders of a majority of these securities will be entitled to make up to three demands that the Company register such securities.
In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent
to the completion of a Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415
under the Securities Act. However the registration rights provides that the Company will not permit any registration statement filed under
the Securities Act to become effective until termination of the applicable lock-up period. The registration rights agreement does
not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities.
The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
The Company granted the underwriters
a 45-day option from the final prospectus relating to the IPO to purchase up to 1,125,000 additional Units to cover over-allotments, if
any, at the IPO price less the underwriting discounts and commissions. On January 21, 2022, the underwriters fully exercised their over-allotment
option and purchased 1,125,000 Units at $10.00 per Unit.
The underwriters were paid
an underwriting discount of $0.20 per unit, or $1,725,000 in the aggregate (including the Overallotment Units), upon the closing of the
IPO. An additional $0.35 per unit, or $3,018,750 in the aggregate, is payable to the underwriters for deferred underwriting commissions.
The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company
completes a Business Combination, subject to the terms of the underwriting agreement.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
Right of First Refusal
Subject to certain conditions,
the Company granted Maxim Group LLC, for a period beginning on the closing of the IPO and ending 18 months after the date of the
consummation of a Business Combination, a right of first refusal to act as lead left book-running managing underwriter with at least
75% of the economics; or, in the case of a three-handed deal 50% of the economics, for any and all future public and private equity,
convertible and debt offerings for the Company or any of the Company’s successors or subsidiaries. In accordance with FINRA Rule 5110(f)(2)(E)(i),
such right of first refusal shall not have a duration of more than three years from the effective date of the IPO.
Unit Purchase Option
The Company sold to the underwriters,
for $100, an option to purchase up to a total of 431,250 Units exercisable, in whole or in part, at $11.00 per Unit, commencing on the
consummation of our initial Business Combination (the “Unit Purchase Option”). The purchase option may be exercised for
cash or on a cashless basis, at the holder’s option, and expires five years from January 18, 2022. The option and the 431,250 Units,
as well as the 431,250 shares of Class A ordinary shares, and the rights to receive 43,125 shares of Class A ordinary shares upon
a Business Combination that may be issued upon exercise of the option, have been deemed compensation by FINRA and are therefore subject
to a lock-up for a period of 180 days immediately following January 18, 2022 pursuant to Rule 5110(e)(1) of FINRA’s Rules, during
which time the option may not be sold, transferred, assigned, pledged or hypothecated, or be subject of any hedging, short sale, derivative
or put or call transaction that would result in the economic disposition of the securities. Additionally, the option may not be sold,
transferred, assigned, pledged or hypothecated for a one-year period (including the foregoing 180-day period) following January 18, 2022
except to any underwriter and selected dealer participating in the offering and their bona fide officers or partners. The option grants
to holders demand and “piggy-back” rights of the securities directly and indirectly issuable upon exercise of the option.
Notwithstanding the foregoing, the underwriters and their related persons may not (i) have more than one demand registration right at
our expense, (ii) exercise their demand registration rights more than five (5) years from January 18, 2022, and (iii) exercise their “piggy-back”
registration rights more than seven (7) years from January 18, 2022. The Company will bear all fees and expenses attendant to registering
the securities, other than underwriting commissions which will be paid for by the holders themselves. The exercise price and number of
units issuable upon exercise of the option may be adjusted in certain circumstances including in the event of a stock dividend, or our
recapitalization, reorganization, merger or consolidation. However, the option will not be adjusted for issuances of shares of ordinary
shares at a price below its exercise price. The Company has no obligation to net cash settle the exercise of the purchase option or the
rights underlying the purchase option. The holder of the purchase option will not be entitled to exercise the purchase option unless a
registration statement covering the securities underlying the purchase option is effective or an exemption from registration is available.
If the holder is unable to exercise the purchase option or underlying rights, the purchase option or rights, as applicable, will expire
worthless.
The Company accounted for
the Unit Purchase Option, inclusive of the receipt of $100 cash payment, as an expense of the IPO resulting in a charge directly to shareholder’s
deficit. The Company estimated the fair value of Unit Purchase Option to be $56,000 based a binomial model.
NOTE 7 — SHAREHOLDERS’ (DEFICIT)
EQUITY
Preference Shares
—The Company is authorized to issue 1,000,000 shares of preference shares with a par value of $0.0001 per shares with such designations,
voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. As of December
31, 2022 and 2021, there were no preference shares issued and outstanding.
Class A Ordinary shares —The
Company is authorized to issue 50,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holders of Class A
ordinary shares are entitled to one vote for each share. As of December 31, 2022 there were 470,975 shares of Class A ordinary shares
outstanding (excluding 8,625,000 shares of Class A ordinary shares subject to possible redemption) and none were outstanding as of December
31, 2021.
Class B Ordinary
shares — The Company is authorized to issue 3,000,000 shares of Class B ordinary shares with a par value of $0.0001
per share. Holders of Class B ordinary shares are entitled to one vote for each share. As of December 31, 2022 and 2021, there were
2,156,250 shares of Class B ordinary shares outstanding.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
Holders of shares of Class
A ordinary shares and shares of Class B ordinary shares will vote together as a single class on all other matters submitted to a vote
of shareholders.
The shares of Class B ordinary
shares will automatically convert into shares of Class A ordinary shares at the time of the initial Business Combination on a one-for-one
basis, subject to adjustment. In the case that additional shares of Class A ordinary shares, or equity-linked securities, are issued or
deemed issued in excess of the amounts offered in the IPO and related to the closing of the initial Business Combination, the ratio at
which shares of Class B ordinary shares shall convert into shares of Class A ordinary shares will be adjusted (unless the holders of a
majority of the outstanding shares of Class B ordinary shares agree to waive such adjustment with respect to any such issuance or deemed
issuance) so that the number of shares of Class A ordinary shares issuable upon conversion of all shares of Class B ordinary shares will
equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all shares of ordinary shares outstanding upon
the completion of the IPO plus all shares of Class A ordinary shares and equity-linked securities issued or deemed issued in connection
with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the
initial Business Combination and any private placement-equivalent warrants issued to the Sponsor or its affiliates upon conversion of
loans made to the Company). Holders of Founder Shares may also elect to convert their shares of Class B ordinary shares into an equal
number of shares of Class A ordinary shares, subject to adjustment as provided above, at any time.
Rights —
Except in cases where the Company is not the surviving company in a Business Combination, each holder of a Public Right will automatically
receive one-tenth (1/10) of one share of Class A ordinary share upon consummation of a Business Combination, even if the holder of a Public
Right converted all shares held by him, her or it in connection with a Business Combination or an amendment to the Company’s Amended
and Restated Certificate of Incorporation with respect to its pre-business combination activities. In the event that the Company will
not be the surviving company upon completion of a Business Combination, each holder of a Public Right will be required to affirmatively
convert his, her or its rights in order to receive the one-tenth (1/10) of a share underlying each Public Right upon consummation of the
Business Combination. No additional consideration will be required to be paid by a holder of Public Rights in order to receive his, her
or its additional shares of Class A ordinary share upon consummation of a Business Combination. The shares issuable upon exchange of the
rights will be freely tradable (except to the extent held by affiliates of the Company). If the Company enters into a definitive
agreement for a Business Combination in which the Company will not be the surviving entity, the definitive agreement will provide for
the holders of rights to receive the same per share consideration the holders of the ordinary shares will receive in the transaction on
an as-converted into ordinary share basis.
The Company will not issue
fractional shares in connection with an exchange of Public Rights. Fractional shares will either be rounded down to the nearest whole
share or otherwise addressed in accordance with the applicable provisions of local law. As a result, the holders of the Public Rights
must hold rights in multiples of 10 in order to receive shares for all of the holders’ rights upon closing of a Business Combination.
If the Company is unable to complete a Business Combination within the Combination Period and the Company liquidates the funds held in
the Trust Account, holders of Public Rights will not receive any of such funds with respect to their Public Rights, nor will they receive
any distribution from the Company’s assets held outside of the Trust Account with respect to such Public Rights, and the Public
Rights will expire worthless. Further, there are no contractual penalties for failure to deliver securities to the holders of the Public
Rights upon consummation of a Business Combination. Additionally, in no event will the Company be required to net cash settle the rights.
Accordingly, the rights may expire worthless.
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
NOTE 8 — FAIR VALUE MEASUREMENTS
The fair value of the Company’s
financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with
the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants
at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the
use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal
assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify
assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
Level 1: Quoted prices
in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for
the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
Level 2: Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.
Level 3: Unobservable
inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
At December 31, 2022, the
assets held in the Trust Account were held in treasury funds. All of the Company’s investments held in the Trust Account are classified
as trading securities. As of December 31, 2021, there were no assets held in the Trust Account.
The following table presents
information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at December 31, 2022
and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
| |
| | |
Quoted Prices in Active Markets | | |
Significant Other Observable Inputs | | |
Significant Other Unobservable Inputs | |
Assets: | |
Level | | |
(Level 1) | | |
(Level 2) | | |
(Level 3) | |
Investment held in Trust Account | |
| 1 | | |
$ | 88,525,575 | | |
| — | | |
| — | |
AIB ACQUISITION CORPORATION
NOTES TO FINANCIAL STATEMENTS
DECEMBER 31, 2022 AND
FOR THE PERIOD FROM JUNE 18, 2021
(INCEPTION) THROUGH DECEMBER
31, 2021
NOTE 9 — SUBSEQUENT
EVENTS
The Company evaluated subsequent events
and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this
review, except as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure
in the financial statements.
On January 19, 2023, upon the shareholders’
approval of the Trust Amendment Proposal, the Company entered into the Trust Amendment to the Investment Management Trust Agreement, dated
January 18, 2022 (the “Trust Agreement”), by and between the Company and Continental, as trustee, to extend the date by which
the Company would be required to consummate a business combination from January 21, 2023 to October 21, 2023, or such earlier date as
determined by the Board, in its sole discretion.
On January 20, 2023, the Company issued the Extension
Note in the aggregate principal amount of up to $450,000 to its sponsor, pursuant to which the Extension Funds will be deposited into
the Trust Account in monthly installments for the benefit of each outstanding Public Share that was not redeemed in connection with the
extension of the Company’s termination date from January 21, 2023 to October 21, 2023. The sponsor has agreed to pay $50,000 per
month (or $0.05 per public share not redeemed) that the Company decides to take to complete an initial business combination, commencing
on January 21, 2023 and continuing through October 21, 2023, or portion thereof, that is needed to complete an initial business combination,
for up to an aggregate of $450,000. On January 20, 2023, the first installment of the Extension Funds was deposited into the Trust Account
(see Note 9). The Extension Note bears no interest and is repayable in full upon the earlier of (a) the date of the consummation of the
initial business combination, and (b) the date of the liquidation of the Company.
The Company will deposit $50,000 per
month into the Trust Account, which equates to approximately $0.05 per remaining Public Share, for each calendar month (commencing on
January 21, 2023 and on the 21st day of each subsequent month) until October 21, 2023, or portion thereof, that is needed to complete
an initial business combination, for up to an aggregate of $450,000. On January 20, 2023, the first installment of the Extension Funds
was deposited into the Trust Account.
In connection with the shareholders’
vote at the extraordinary general meeting of shareholders held on January 18, 2023, shareholders holding 7,623,698 shares of the Company’s
ordinary shares exercised their right to redeem such shares for a pro rata portion of the funds in the Company’s Trust Account.
As a result, $78,324,476 (approximately $10.27 per share) will be removed from the Trust Account to pay such holders.
On January 23, 2023, the Company issued the Third
Note in the principal amount of up to $500,000 to the Sponsor. The Note was issued in connection with advances the Sponsor has made, and
may make in the future, to the Company for working capital expenses. The Note bears no interest and is due and payable upon the earlier
to occur of (i) the date on which the Company consummates its initial business combination and (ii) the date that the winding up of the
Company is effective. At the election of the Sponsor, up to $500,000 of the unpaid principal amount of the Note may be converted into
units of the Company, each unit consisting of one Class A ordinary share of the Maker and one right exchangeable into one-tenth of one
Class A ordinary share of the Company (the “Conversion Units”), equal to: (x) the portion of the principal amount of this
Note being converted, divided by (y) $10.00, rounded up to the nearest whole number of units. The Conversion Units are identical to the
units issued by the Company to the Sponsor in the private placement upon consummation of the Company’s initial public offering.
The Conversion Units and their underlying securities are entitled to the registration rights set forth in the Note.